Emicizumab Prophylaxis in People with Moderate or Mild Hemophilia A Aged 40 Years, with and without Comorbidities - Findings from the Phase III HAVEN 6 StudyVictor Jimenez-Yuste,Eunice Tzeng, Elise Lim,Giuliana Ventriglia,Amy D. Shapiro,Johannes Oldenburg,Johnny MahlanguBLOOD(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要